{"id":"NCT00259272","sponsor":"Eli Lilly and Company","briefTitle":"Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine","officialTitle":"Phase IIIb, Multicenter, Single-Arm Open-Label Study, Supporting the Development and the Validation of the MATHYS Scale (Multidimensional Assessment of THYmic States) in a Population of Bipolar Patients Treated With Olanzapine, Either in-Label (Manic and Mixed Patients) and Off-Label (Hypomanic and Bipolar Depression)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-11","primaryCompletion":"2008-05","completion":"2008-05","firstPosted":"2005-11-29","resultsPosted":"2009-06-24","lastUpdate":"2009-06-24"},"enrollment":141,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar Disorder I or II"],"interventions":[{"type":"DRUG","name":"olanzapine","otherNames":["LY170053","Velotab","Zydis"]}],"arms":[{"label":"A","type":"EXPERIMENTAL"}],"summary":"A non randomized study to validate the MATHYS Scale in a population of in and outpatients greater than or equal to 18 years of age, suffering from Bipolar Disorder I or II, and treated with olanzapine.","primaryOutcome":{"measure":"Mean Changes From Baseline to 6 Week and 24 Week Endpoints in the Multidimensional Assessment of THYmic States Scale (MATHYS) Total Score","timeFrame":"Baseline, 6 Weeks, 24 weeks","effectByArm":[{"arm":"Manic Episode","deltaMin":140.55,"sd":22.18},{"arm":"Hypomanic Episode","deltaMin":136.52,"sd":22.45},{"arm":"Mixed Episode","deltaMin":116.74,"sd":21.3},{"arm":"Depressive Episode","deltaMin":76.88,"sd":22.91}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":16,"countries":["France"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14},"commonTop":["Dry mouth","Constipation","Somnolence","Tremor","Asthenia"]}}